We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Medical Properties (MPW) Stock Drops Despite Market Gains: Important Facts to Note
Read MoreHide Full Article
Medical Properties (MPW - Free Report) closed at $4.03 in the latest trading session, marking a -1.23% move from the prior day. This change lagged the S&P 500's 0.14% gain on the day. Meanwhile, the Dow experienced a drop of 0.04%, and the technology-dominated Nasdaq saw an increase of 0.38%.
The health care real estate investment trust's stock has dropped by 8.11% in the past month, falling short of the Finance sector's gain of 4.07% and the S&P 500's gain of 5.35%.
Market participants will be closely following the financial results of Medical Properties in its upcoming release. The company is predicted to post an EPS of $0.13, indicating a 43.48% decline compared to the equivalent quarter last year. At the same time, our most recent consensus estimate is projecting a revenue of $228.55 million, reflecting a 14.26% fall from the equivalent quarter last year.
For the full year, the Zacks Consensus Estimates project earnings of $0.55 per share and a revenue of $919.34 million, demonstrating changes of -31.25% and -7.65%, respectively, from the preceding year.
Investors might also notice recent changes to analyst estimates for Medical Properties. These revisions typically reflect the latest short-term business trends, which can change frequently. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 2.35% lower. Medical Properties currently has a Zacks Rank of #3 (Hold).
With respect to valuation, Medical Properties is currently being traded at a Forward P/E ratio of 7.37. This signifies a discount in comparison to the average Forward P/E of 11.19 for its industry.
The REIT and Equity Trust - Other industry is part of the Finance sector. With its current Zacks Industry Rank of 161, this industry ranks in the bottom 35% of all industries, numbering over 250.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Medical Properties (MPW) Stock Drops Despite Market Gains: Important Facts to Note
Medical Properties (MPW - Free Report) closed at $4.03 in the latest trading session, marking a -1.23% move from the prior day. This change lagged the S&P 500's 0.14% gain on the day. Meanwhile, the Dow experienced a drop of 0.04%, and the technology-dominated Nasdaq saw an increase of 0.38%.
The health care real estate investment trust's stock has dropped by 8.11% in the past month, falling short of the Finance sector's gain of 4.07% and the S&P 500's gain of 5.35%.
Market participants will be closely following the financial results of Medical Properties in its upcoming release. The company is predicted to post an EPS of $0.13, indicating a 43.48% decline compared to the equivalent quarter last year. At the same time, our most recent consensus estimate is projecting a revenue of $228.55 million, reflecting a 14.26% fall from the equivalent quarter last year.
For the full year, the Zacks Consensus Estimates project earnings of $0.55 per share and a revenue of $919.34 million, demonstrating changes of -31.25% and -7.65%, respectively, from the preceding year.
Investors might also notice recent changes to analyst estimates for Medical Properties. These revisions typically reflect the latest short-term business trends, which can change frequently. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 2.35% lower. Medical Properties currently has a Zacks Rank of #3 (Hold).
With respect to valuation, Medical Properties is currently being traded at a Forward P/E ratio of 7.37. This signifies a discount in comparison to the average Forward P/E of 11.19 for its industry.
The REIT and Equity Trust - Other industry is part of the Finance sector. With its current Zacks Industry Rank of 161, this industry ranks in the bottom 35% of all industries, numbering over 250.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.